Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12590
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vella, Laura J | en |
dc.contributor.author | Andrews, Miles C | en |
dc.contributor.author | Pasam, Anupama | en |
dc.contributor.author | Woods, Katherine | en |
dc.contributor.author | Behren, Andreas | en |
dc.contributor.author | Cebon, Jonathan S | en |
dc.date.accessioned | 2015-05-16T02:18:23Z | |
dc.date.available | 2015-05-16T02:18:23Z | |
dc.date.issued | 2014-07-03 | en |
dc.identifier.citation | Oncoimmunology 2014; 3(7): e946367 | en |
dc.identifier.govdoc | 25610732 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/12590 | en |
dc.description.abstract | Metastatic melanoma is frequently fatal. Optimal treatment regimens require both rapid and durable disease control, likely best achieved by combining targeted agents with immunotherapeutics. In order to accomplish this, a detailed understanding of the immune consequences of the kinase inhibitors used to treat melanoma is required. | en |
dc.language.iso | en | en |
dc.subject.other | BRAF | en |
dc.subject.other | MEK | en |
dc.subject.other | T-lymphocytes | en |
dc.subject.other | dendritic cells | en |
dc.subject.other | melanoma | en |
dc.title | The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Oncoimmunology | en |
dc.identifier.affiliation | Ludwig Institute for Cancer Research; Melbourne-Austin Branch; Cancer Immuno-biology Laboratory ; Heidelberg, Australia | en |
dc.identifier.doi | 10.4161/21624011.2014.946367 | en |
dc.description.pages | e946367 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/25610732 | en |
dc.type.austin | Journal Article | en |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.